News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
European Commission Approves New Innovative Cancer Treatment from Major Biopharma Company
Wednesday, September 03, 2025
New Clinical Trial Initiated for Alzheimer's Disease Drug in Multiple European Countries
Wednesday, September 03, 2025
OMass Therapeutics Signs Exclusive Collaboration and Licence Agreement with Genentech for Inflammatory Bowel Disease Therapies
Wednesday, September 03, 2025OMass Therapeutics has entered into an exclusive collaboration and licence agreement with Genentech part of the Roche Group to develop and commercialise its preclinical oral small molecule programme for inflammatory bowel disease IBD
Polpharma Biologics and MS Pharma Sign Licence Agreement for Biosimilar Candidates Vedolizumab, Ocrelizumab and Guselkumab
Wednesday, September 03, 2025Polpharma Biologics has entered into a licence agreement with MS Pharma for the commercialisation of three biosimilar candidates vedolizumab PB ocrelizumab PB and guselkumab PB
European Medicines Agency Approves New mRNA Vaccine for Agriculture Use
Tuesday, September 02, 2025The European Medicines Agency EMA has officially approved a cuttingedge mRNA vaccine designed for use in livestock marking a significant advancement in agricultural biotechnology
Partnership Formed to Accelerate Gene Therapy Development in Europe
Tuesday, September 02, 2025A new partnership has been established among several leading biotech companies in Europe with the aim of accelerating research and development in the gene therapy sector This consortium combines expertise from various fields
European Biotech Firm Launches Groundbreaking Gene Therapy Trial for Rare Disease
Monday, September 01, 2025In an exciting development for the European life sciences sector a prominent biotech firm has announced the launch of a groundbreaking gene therapy trial aimed at addressing rare genetic disorders
German Manufacturing Facility Receives Regulatory Approval for Biologics Production
Monday, September 01, 2025In a significant development for the biopharmaceutical sector a leading manufacturing facility in Germany has obtained regulatory approval to commence the production of biologic drugs
European Biopharma Industry Leads Global Growth with Increased R&D Investments
Saturday, August 30, 2025
European Union Revises Clinical Trial Regulations to Enhance Patient Safety and Data Transparency
Saturday, August 30, 2025
